Pharma BI: The Advantages of Being Vertically Focused

, , ,
I recently attended a conference on cloud based commercial support systems – covering all facets of customer facing functions, from SFA to Customer Service to BI. The giant vendor expo hall buzzed with dozens upon dozens of vendors all vying…

Capitalizing on the Affordable Care Act

,
We’ve all heard about the rollout the Affordable Care Act and the website’s technical issues. Despite that, enrollment numbers are improving and gaining strength. In fact, January’s numbers actually exceeded the month’s enrollment target…

Driving Success Leveraging Pharmaceutical Big Data

, ,
The term Big Data is everywhere these days. As analytics professionals, it’s almost unavoidable; every company, from every industry, seems to be talking about it. But, what does it mean and how does it apply to the pharmaceutical industry?…

Commercial Pharma and EHR - State of the Industry

, ,
With federal financial incentives to install electronic health record systems, more and more physicians are beginning to integrate these tools into their practices. In fact, in 2005 it is estimated that only 30% of HCP offices and hospitals…

Tips & Tricks to Guarantee You Never Enter a Sales Call Blindly Again!

,
I never have the right information when I’m going into a sales call! I feel like I’m always scrambling to find the right statistics! I waste all my time driving from appointment to appointment! I feel like I’m going into sales call blindly!…

Is Launching an Oncology Drug a Harder Sell?

As anyone selling to Oncologists might tell you, being a specialty sales rep to this therapeutic area is probably one of the most complex pharma sales roles today. Why is that? More and more companies are adding oncology pipelines, more drugs…

Do sales reps still matter?

,
Over the past few years, it’s no secret that pharmaceutical companies are making significant reductions in the size of their sales “armies.” The days of the “arms race,” where more reps meant more detailing, are over. Physicians are…

Managing Multiple Drug Launches

,
Traditionally Pharma companies used to launch one or two blockbuster assets a year. This resulted in a one-size-fits-all approach to their launches regarding positioning, go-to-market strategy and resourcing. Today the pharmaceutical industry…

Optimizing Life Science Analytical Solutions – Part 2

,
Analytical Solutions are ultimately about improving business performance. If your solution is underutilized, chances are it isn’t useful enough. In our previous blog, we discussed some ways to substantially improve analytics performance for…

Reflections on Bayer’s 2014 Plan of Action Event

, , ,
Last week was a truly invigorating experience. Along with Doron Aspitz, Verix’s CEO and Yaron Makleff, Director of Services, I attended Bayer’s annual POA (Plan of Action) event at the Rosen Shingle Creek hotel in Orlando, FL. Bayer’s…